Challenges in the Clinical Advancement of Cell Therapies for Parkinson’s Disease

Scientists discuss how challenges pertaining to cell sources, functional and safety testing, manufacturing, and address clinical-trial design to advance the development of cell therapies for Parkinson’s disease.